Bringing Data Quality To The CRO-BioPharma Partnership

Growth in biotech and large pharma companies is being driven by the rising number of drugs in preclinical trials, an increase in outsourcing R&D activities, and more product pipelines in biotech. Many biotechs believe there is great benefit partnering with a CRO in R&D but reports show they feel underserved by these relationships. In the highly competitive CRO market, where compliance, quality and data integrity are critical to winning and retaining business, today’s sponsors require a high degree of confidence in their CRO partners.

Learn about the use of CRO's in response to growth in pharma companies, R&D spending and activity, and rising number of drugs in preclinical trials.